Literature DB >> 23651403

Supercritical fluid particle design for poorly water-soluble drugs (review).

Yongda Sun1.   

Abstract

Supercritical fluid particle design (SCF PD) offers a number of routes to improve solubility and dissolution rate for enhancing the bioavailability of poorly water-soluble drugs, which can be adopted through an in-depth knowledge of SCF PD processes and the molecular properties of active pharmaceutical ingredients (API) and drug delivery system (DDS). Combining with research experiences in our laboratory, this review focuses on the most recent development of different routes (nano-micron particles, polymorphic particles, composite particles and bio-drug particles) to improve solubility and dissolution rate of poorly water-soluble drugs, covering the fundamental concept of SCF and the principle of SCF PD processes which are typically used to control particle size, shape, morphology and particle form and hence enable notable improvement in the dissolution rate of the poorly water-soluble drugs. The progress of the industrialization of SCF PD processes in pharmaceutical manufacturing environment with scaled-up plant under current good manufacturing process (GMP) specification is also considered in this review.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23651403     DOI: 10.2174/13816128113199990404

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Development of a high-pressure set-up for measurements of binary diffusion coefficients in supercritical carbon dioxide.

Authors:  S Ancherbak; C Santos; J C Legros; A Mialdun; V Shevtsova
Journal:  Eur Phys J E Soft Matter       Date:  2016-11-24       Impact factor: 1.890

2.  Supercritical carbon dioxide decellularization of plant material to generate 3D biocompatible scaffolds.

Authors:  Ashlee F Harris; Jerome Lacombe; Sumedha Liyanage; Margaret Y Han; Emily Wallace; Sophia Karsunky; Noureddine Abidi; Frederic Zenhausern
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.